1. Academic Validation
  2. Trifluoromethylation of dihydrocoptisines and the effect on structural stability and XBP1-activating activity

Trifluoromethylation of dihydrocoptisines and the effect on structural stability and XBP1-activating activity

  • J Asian Nat Prod Res. 2022 Apr;24(4):388-396. doi: 10.1080/10286020.2021.1935895.
Xiang Li 1 Hai-Jing Zhang 1 Zhi-Hong Li 1 Lian-Qiu Wu 1 An-Jun Deng 1 Hai-Lin Qin 1
Affiliations

Affiliation

  • 1 State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Abstract

In order to obtain new dihydrocoptisine-type compounds with stable structure and activating XBP1 transcriptional activity, (±)-8-trifluoromethyldihydrocoptisine derivatives as target compounds were synthesized from quaternary ammonium chlorides of coptisine Alkaloids as starting Materials by a one-step reaction. The structures of the synthesized compounds were confirmed by 1H-, 13C-, and 19F-NMR as well as HRESIMS methods. These compounds showed more significant structural stability and activating XBP1 transcription activity in vitro than dihydrocoptisine as positive control. No obvious cytotoxicity on normal cell in vitro was observed with (±)-8-trifluoromethyldihydrocoptisines. Trifluoromethylation can be used as one of the fluorine modification strategies for dihydrocoptisines to guide follow-up studies on structural modification of coptisine-type Alkaloids and on anti-Ulcerative colitis drugs with coptisines.

Keywords

trifluoromethylation; (±)-8-trifluoromethyldihydrocoptisines; Dihydrocoptisines; XBP1-activating activity; structural stability.

Figures
Products